Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Income (loss) $ 603,105 $ (785,520)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:    
Depreciation and amortization 626,315 744,592
Allowance for bad debts 710,852
Stock based compensation 628,776 473,782
Gain on sale of equipment (17,400)
Changes in operating assets and liabilities:    
Accounts receivable (2,532,046) (2,293,779)
Prepaid expenses and other current assets (274,334) (223,672)
Employee loans (401,517) (308,790)
Other Assets (113,980)
Accounts payable and accrued expenses 348,020 416,165
Income taxes payable 24,754
Deferred rent 61,781 130,169
Unearned income (16,375) 17,702
Net cash used in operating activities (1,062,901) (1,118,499)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of equipment 17,400
Purchase of interest in Crane Creek Surgical Center (400,000)
Purchase of equipment (685,964) (281,618)
Net cash (used in) provided by investing activities (1,068,564) (281,618)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock 7,500,000
Proceeds from settlement, due to non-controlling interest 6,521,655
Proceeds from notes payable 338,245 86,713
Proceeds from line of credit 500
Purchase of treasury stock (187,121)
Payments on notes payable (44,517) (397,595)
Net cash used in financing activities 7,793,728 6,024,152
Net increase in cash 5,662,263 4,624,035
Cash, beginning of period 2,015,534 4,593,638
Cash, end of period 7,677,797 9,217,673
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Cash paid during the period for interest 95,211 90,386
Cash paid during the period for taxes